CooperCompanies stock falls after revenue miss and legal probes
Published on 09/16/2026 at 23:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CooperCompanies stock (ISIN US21664P1039) ended trading on the Nasdaq at USD 53.27 on September 15, 2026, extending a sharp pullback that followed a weaker than expected quarterly revenue print and mounting legal scrutiny of the company.
Revenue miss and guidance weigh on shares
According to Business Wire on September 16, 2026, CooperCompanies reported quarterly revenue of approximately USD 1.07 billion versus roughly USD 1.10 billion expected, a shortfall of about USD 30 million that disappointed investors.
In the same communication, management highlighted that U.S. channel inventory reductions at its CooperVision unit would continue into the following quarter, signaling that near term growth will remain constrained as distributors and eye care professionals work down excess stock.Business Wire
Further detail on the outlook shows that for the fourth quarter of fiscal 2026 CooperCompanies expects consolidated revenue of USD 1.057 billion to USD 1.08 billion and non-GAAP EPS of USD 1.05 to USD 1.09, with CooperSurgical growing mid single digits and CooperVision flat to slightly down.TipRanks This guidance implies modest sequential revenue growth from the USD 1.07 billion reported for the recent quarter but with limited earnings expansion as the company balances volume pressure and higher taxes.
Analysts cut price targets and highlight risks
The softer revenue and cautious channel commentary have prompted a wave of analyst target cuts. Citigroup reaffirmed a neutral rating and lowered its price target on CooperCompanies stock from USD 80.00 to USD 60.00 in a research note dated September 10, 2026.MarketBeat On the same day, Bank of America also maintained a neutral stance while cutting its target from USD 80.00 to USD 65.00, underscoring reduced upside expectations.
Robert W. Baird set a USD 61.00 price target with a neutral rating in a September 10, 2026 report, adding to a cluster of revised views that now range mostly between USD 60 and USD 65 compared with the previous USD 80 level.MarketBeat Zacks Research went further, downgrading CooperCompanies from a hold rating to a strong sell rating in a research note published shortly after, reflecting concerns about near term earnings momentum.MarketBeat
Despite these cuts, data compiled by MarketBeat indicate that CooperCompanies still carries a consensus rating of Hold from the analyst community, with five Buy ratings, eleven Hold ratings and three Sell ratings and an average target price of USD 71.47, leaving the current market price roughly USD 18 below the average 12 month target.
Legal investigations add pressure, but insiders buy
The stock’s pullback has been sharpened by legal headlines. As reported by Business Wire on September 16, 2026, the law firm Levi & Korsinsky announced a pending investigation into potential securities claims involving CooperCompanies, focusing on whether the company’s disclosures adequately reflected its operational and inventory challenges.
Separately, Kirby McInerney LLP publicized a securities investigation in a release cited by Ad-hoc-news, noting that CooperCompanies stock had fallen from USD 63.48 on September 9, 2026 to close at USD 54.17 on September 10, a drop of USD 9.31 or approximately 14.7 percent over that period. This decline framed the weaker close at USD 53.27 on September 15 and underscored how the investigation headlines intensified selling pressure.
Against this backdrop, insider activity has taken a more constructive tone. In a Form 4 filing summarized by GuruFocus, Director Lawrence Kurzius purchased 10,000 shares of CooperCompanies common stock on September 14, 2026, bringing his total holdings to 21,099 shares. Shares were trading at USD 53.92 on the day of his purchase, giving the company a market capitalization of USD 10.13 billion and implying a price earnings ratio of 18.18, below both the industry median of 23.86 and the company’s historical median valuation multiple.
Earnings outlook and investor perspective
On the recent earnings call, management emphasized that despite near term headwinds in CooperVision’s U.S. channel, the broader business remains positioned to generate robust cash flows. According to TipRanks, CooperCompanies is targeting approximately USD 170 million of free cash flow in the fourth quarter of fiscal 2026 and about USD 2.2 billion of cumulative free cash flow over fiscal years 2026 to 2028, even as its effective tax rate rises in fiscal 2027.
These cash generation ambitions sit alongside the company’s share repurchase plans. As MarketBeat reports, CooperCompanies’ board approved a stock buyback authorization on September 9, 2026 allowing the company to repurchase up to USD 3.00 billion of shares, equivalent to as much as 22.7 percent of its outstanding stock through open market purchases. For investors, the combination of a lower share price, insider buying and a sizable buyback plan creates a potential support factor, even as legal and operational uncertainties persist.
Stock trades below analyst targets
CooperCompanies stock was last reported trading at USD 53.27 on the Nasdaq on September 15, 2026, compared with the USD 63.48 level seen on September 9, placing the shares roughly USD 10 below their recent level and around USD 18 below the consensus analyst target price of USD 71.47 compiled by MarketBeat.Ad-hoc-newsMarketBeat With a market capitalization of about USD 10.13 billion at USD 53.92 per share on September 14, 2026, the stock now trades on a price earnings ratio of 18.18, leaving room for rerating if growth and margin trends stabilize.GuruFocus
CooperCompanies stock at a glance
- Company: CooperCompanies Inc.
- ISIN: US21664P1039
- Ticker: COO
- Trading venue: Nasdaq
- Price (as of September 15, 2026): 53.27 USD
- Market capitalization: 10,130,000,000 USD (as of September 14, 2026)
- Sector / Industry: Health care / Medical devices
- Index membership: S&P 500
